SERIAL PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN ACUTE MULTIPLE-SCLEROSIS LESIONS

被引:456
作者
DAVIE, CA
HAWKINS, CP
BARKER, GJ
BRENNAN, A
TOFTS, PS
MILLER, DH
MCDONALD, WI
机构
[1] NMR Research Group, Institute of Neurology, Queen Square, London
关键词
NMR SPECTROSCOPY; MULTIPLE SCLEROSIS; DEMYELINATION; LIPIDS; N-ACETYLASPARTATE;
D O I
10.1093/brain/117.1.49
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Serial proton magnetic resonance spectroscopy (MRS), was carried out at 1-2 monthly intervals on eight patients with multiple sclerosis who presented with evidence of a large acute cerebral white matter lesion. An MRS was obtained from acute lesions (volumes of interest 4-12 ml), which at presentation showed gadolinium-diethylenetriamine penta-acetic acid enhancement, and from similar volumes of normal appearing white matter lateral to the lesion and nearer the scalp. Followup ranged from 4 to 9 months (mean 6 months). Short echo spectra from acute enhancing lesions invariably showed the presence of large resonances at 0.9 and 1.3 p.p.m. compared with normal appearing white matter and healthy age marched controls, indicating that these peaks were nor the result of voxel contamination from scalp fat. These resonances, which probably represent lipid products of myelin breakdown, were detected in lesions which had been enhancing for <1 month and remained elevated for a mean of 5 months (range 4-8 months). The results provide evidence that short echo proton MRS can detect myelin breakdown products and that myelin breakdown occurs during the initial inflammatory stage of lesion development. The ratio of N-acetylaspartate (NAA) (a neuronal marker) relative to creatine was reduced in acute lesions and in normal appearing white matter. In six of the lesions studied there was, however, a subsequent rise in the NAA/creatine ratio indicating that axonal loss is nor the only mechanism of reduction in the NAA/creatine ratio.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 54 条
  • [21] DURATION AND SELECTIVITY OF BLOOD-BRAIN-BARRIER BREAKDOWN IN CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS STUDIED BY GADOLINIUM-DTPA AND PROTEIN MARKERS
    HAWKINS, CP
    MUNRO, PMG
    MACKENZIE, F
    KESSELRING, J
    TOFTS, PS
    DUBOULAY, EPGH
    LANDON, DN
    MCDONALD, WI
    [J]. BRAIN, 1990, 113 : 365 - 378
  • [22] INGLIS BA, 1992, 11TH P ANN M SOC MAG, P2162
  • [23] JW D., 1916, EDINBURGH MED J, V17, P229, DOI DOI 10.1017/S0080456800027174
  • [24] CORRELATION BETWEEN MAGNETIC-RESONANCE-IMAGING FINDINGS AND LESION DEVELOPMENT IN CHRONIC, ACTIVE MULTIPLE-SCLEROSIS
    KATZ, D
    TAUBENBERGER, JK
    CANNELLA, B
    MCFARLIN, DE
    RAINE, CS
    MCFARLAND, HF
    [J]. ANNALS OF NEUROLOGY, 1993, 34 (05) : 661 - 669
  • [25] KATZ D, 1990, ANN NEUROL, V28, P243
  • [26] KAUPPINEN RA, 1992, J BIOL CHEM, V267, P9905
  • [27] BREAKDOWN OF THE BLOOD-BRAIN-BARRIER PRECEDES SYMPTOMS AND OTHER MRI SIGNS OF NEW LESIONS IN MULTIPLE-SCLEROSIS - PATHOGENETIC AND CLINICAL IMPLICATIONS
    KERMODE, AG
    THOMPSON, AJ
    TOFTS, P
    MACMANUS, DG
    KENDALL, BE
    KINGSLEY, DPE
    MOSELEY, IF
    RUDGE, P
    MCDONALD, WI
    [J]. BRAIN, 1990, 113 : 1477 - 1489
  • [28] MAGNETIC-RESONANCE SPECTROSCOPY OF MULTIPLE-SCLEROSIS - INVIVO DETECTION OF MYELIN BREAKDOWN PRODUCTS
    KOOPMANS, RA
    LI, DKB
    ZHU, G
    ALLEN, PS
    PENN, A
    PATY, DW
    [J]. LANCET, 1993, 341 (8845) : 631 - 632
  • [29] KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
  • [30] LOCALIZED INVIVO PROTON SPECTROSCOPY IN THE BRAIN OF PATIENTS WITH MULTIPLE-SCLEROSIS
    LARSSON, HBW
    CHRISTIANSEN, P
    JENSEN, M
    FREDERIKSEN, J
    HELTBERG, A
    OLESEN, J
    HENRIKSEN, O
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1991, 22 (01) : 23 - 31